Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 91 to 100 of 100 results for innovative solutions

  1. Daridorexant for treating long-term insomnia (TA922)

    Evidence-based recommendations on daridorexant (QUVIVIQ) for treating long-term insomnia in adults.

  2. Research recommendations

    chlorhexidine in alcohol versus 2% chlorhexidine aqueous solution versus 0.5% chlorhexidine aqueous solution for cleansing...

  3. Methods for the development of NICE public health guidance (third edition) (PMG4)

    Methods for the development of NICE public health guidance (third edition)

  4. NHS at 75

    Dr Sam Roberts, chief executive of NICE, celebrates the NHS on its 75th anniversary. She discusses how NICE has supported the NHS with its recent achievements. She also highlights how NICE is evolving; through driving value-based healthcare to support the NHS as it adapts to meet current challenges.

  5. NICE's support for rebuilding capacity in non-COVID health services

    Director of our Centre for Guidelines, Paul Chrisp, discusses how NICE can help the NHS and wider care sector restore services most affected by the COVID-19 pandemic

  6. New collaboration between NICE and The Academic Health Science Network will help embed innovations into the healthcare system for the benefit of patients

    The agreement will draw on the strengths, skills, and resources of both organisations in order to seize every opportunity to support the healthcare system in adopting evidence-based healthcare and innovations.

  7. NICE recommends elosulfase alfa for routine NHS use for patients with rare life-limiting metabolic disorder

    People with a rare condition that steadily worsens often leaving them dependent on a wheelchair and with shortened life expectancy, can now benefit from the first treatment to slow its progression.

  8. Wireless device recommended for treating people with overactive bladder

    Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years

  9. A 'safe space' for addressing complex health technology assessment challenges

    Nick Crabb discusses how we’re developing a collaborative space for research and development, to help us create new methods and processes for health technology assessment.

  10. Speaking with one language: How using a common data model might speed up decision making

    NICE is taking part in the European Health Data and Evidence Network (EHDEN) project, which is exploring the use of common data models for healthcare research. This could support faster patient access to innovative medicines in areas of unmet need.